Sonia Hernández-Díaz is a Spanish-born American epidemiologist who is Professor of Epidemiology in the Harvard T.H. Chan School of Public Health. At the HUSPH, she is Director of the Pharmacoepidemiology program and assistant professor of epidemiology at the Boston University School of Public Health.[1] Her research focuses on the evaluation of drug safety, especially during pregnancy. She has served as president of the International Society for Pharmacoepidemiology and the Society for Pediatric and Perinatal Epidemiologic Research, and is the chair of the Food and Drug Administration's Drug Safety and Risk Management Advisory Committee.[2] During the COVID-19 pandemic, she began researching the effects of COVID-19 on pregnant women and their fetuses.[3]
Sonia Hernández-Díaz | |
|---|---|
| Born | |
| Education | |
| Known for | Research on drug safety during pregnancy |
| Awards | Fellow of the International Society for Pharmacoepidemiology |
| Scientific career | |
| Fields | Epidemiology |
| Institutions | Harvard T.H. Chan School of Public Health, Boston University School of Public Health |
Hernández-Díaz is one of the creators of International Registry of Coronavirus Exposure in Pregnancy (IRCEP) which is a website for pregnant women who may have been exposed to COVID-19 and need a resource guide. I [4]
References
edit- ^ "Sonia Hernandez-Diaz, MD". Boston University School of Public Health. Retrieved 20 October 2022.
- ^ Boston, 677 Huntington Avenue; Ma 02115 +1495‑1000 (2021-01-05). "Sonia Hernández-Díaz". Harvard T.H. Chan School of Public Health. Retrieved 2021-04-01.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ^ Wong, Matteo (2020-08-19). "Gravid and COVID". Harvard Magazine. Retrieved 2021-04-01.
- ^ "Department of Epidemiology Coronavirus (COVID-19) News". Harvard TC Chan School of Public Health. 2 April 2020. Retrieved 20 October 2022.
External links
edit
  | This article about an American scientist in academia is a stub. You can help Wikipedia by expanding it. |